BioCentury
ARTICLE | Company News

Lpath management update

November 10, 2014 8:00 AM UTC

Lpath Inc. (NASDAQ:LPTN), San Diego, Calif. Business: Cancer, Ophthalmic Resigned: Scott Pancoast as president, CEO, and a director; he is succeeded by interim CEO Michael Lack ...